arrow
A

Alexandre Vasiljevic

cancer research center of lyon
H指数:47
被引数:8,309

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type

关于一种低级别弥漫性浸润性肿瘤的新观察,<i>SMARCB1</i>突变,论证了一种新的肿瘤类型

2026-09-080
OAAI
Prospective Multicenter Evaluation of [11C]Methionine PET/MRI Sensitivity Compared with MRI for Localizing Small Pituitary Neuroendocrine Tumor or Pituitary Adenoma in Cushing Disease

前瞻性多中心评估[11C]蛋氨酸PET/MRI在定位库欣病中小型垂体神经内分泌肿瘤或垂体腺瘤方面的敏感性,并与MRI进行比较。

2025-10-010
OAAI
PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alteration

PLAG1融合定义了具有PLAG家族基因改变的中枢神经系统胚胎性肿瘤的第三种亚型

2025-08-020
OAAI
Comparative Clinical and Imaging-Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL Amplification

伴有PLAGL基因扩增的中枢神经系统胚胎性肿瘤治疗方案的临床与影像学比较评估

2025-04-010
OAAI
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2024-10-070
OA
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI Analysis
2024-09-130
PRE
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors

Sno-eano-euracan松果体实质肿瘤管理共识

2024-07-290
OA
PIT-EASY survey: validation of the European Pituitary Pathology Group proposal for reporting pituitary neuroendocrine tumors

PIT-EASY调查: 欧洲垂体病理学组报告垂体神经内分泌肿瘤的建议的验证

2024-06-224
PRE
NANOPORE SEQUENCING AS A CUTTING-EDGE TECHNOLOGY FOR MEDULLOBLASTOMA CLASSIFICATION
2024-06-180
OAAI
SUBGROUP AND SUBTYPE-SPECIFIC OUTCOMES IN METASTATIC INFANT MEDULLOBLASTOMA
2024-06-180
OAAI
EVALUATING THERAPEUTIC APPROACHES IN EMBRYONAL TUMORS WITH PLAGL1 AND PLAGL2 AMPLIFICATION AND UNRAVELING MOLECULAR PARALLELS IN EPIGENETICALLY RELATED TUMORS WITH PLAG1-ALTERATIONS
2024-06-180
OAAI
Preoperative 11C-Methionine PET-MRI in Pediatric Infratentorial Tumors
2024-03-150
OA